Duvelisib Warnings and Precautions

Duvelisib (Duvelisib) is a new drug used to treat certain types of lymphoma and leukemia. Although it has shown significant results in improving patients' condition, it also comes with some important warnings and precautions. Patients need to closely follow their doctor's recommendations when using duvelised to ensure optimal treatment results while minimizing potential risks and adverse reactions.

The following are warnings and notes regarding Duvilise:

1. Risk of infection: Duveliced may increase the risk of infection. Patients should be regularly monitored for infection during treatment and should try to avoid contact with sources of infection. If symptoms of infection occur, such as fever, chills, sore throat, cough, frequent urination, diarrhea, etc., you should inform your doctor immediately.

2. Pneumonia risk: Use of duveliced may cause pneumonia, including bacterial and fungal pneumonia. Patients need to closely observe respiratory symptoms, such as shortness of breath, cough, chest pain, etc., and inform their doctor as soon as possible if they feel uncomfortable.

3. Diarrhea: Diarrhea may occur during use of duvelisel. If diarrhea is severe or prolonged, patients should inform their doctor so that appropriate management measures can be taken to prevent dehydration and electrolyte imbalance.

4. Skin reactions: Patients may experience skin reactions such as rash, itching, dryness, flushing, or pain. These reactions usually subside after treatment is discontinued or the dose is reduced. Patients should follow their doctor's recommendations and keep their skin clean and moisturized.

5. Hyperglycemia: The use of duveliced may cause hyperglycemia. Patients should monitor blood sugar levels regularly, especially those at risk for diabetes.

6. Abnormal liver function: Duvelised may cause abnormal liver function. Patients require regular liver function monitoring during treatment. If liver function abnormalities occur, your doctor may take appropriate measures, including reducing or stopping medications.

7. Abnormal renal function: The use of duveliced may have an impact on renal function. Patients need to have regular kidney function monitoring and notify their doctor if abnormalities occur.

8. Bleeding risk: Duvelised may increase the risk of bleeding, including serious bleeding. Patients need to pay attention to any abnormal bleeding symptoms, such as persistent nosebleeds, hematuria, melena, purpura, etc., and inform the doctor in time.

9. Allergic reaction: Individual patients may have allergic reactions to duvelised, manifesting as rash, urticaria, shortness of breath, throat swelling, etc. If allergic symptoms occur, patients should seek medical attention immediately.

10. Interactions: Duveliced may interact with other drugs, affecting their metabolism and efficacy. Patients should provide their doctor with a detailed medication list to ensure that potential adverse interactions are avoided.

11. Pregnant and lactating women: Duvelisel may cause damage to the fetus and is therefore not recommended for use by pregnant women. Breastfeeding women should avoid breastfeeding or stop breastfeeding to reduce the risk of the drug being passed to the baby through breast milk.

Patients should discuss the potential risks and benefits in detail with their doctor before using duveliset and follow their doctor's recommendations. Physicians will determine whether duvelised is appropriate for use and how treatment should be monitored and managed based on the patient's specific circumstances. Close collaboration between the patient and medical team is critical to ensuring the safety and effectiveness of treatment. If patients experience unusual symptoms or suspected adverse reactions, they should contact their doctor immediately to obtain timely medical advice and intervention.

The original drug of Duvelisel Capsules has been launched in China, but it is not covered by medical insurance. Patients can buy it domestically at a price of more than 20,000 yuan. For specific prices, please consult the local hospital pharmacy.